Literature DB >> 3109324

Studies on the rate-determining factor in testosterone hydroxylation by rat liver microsomal cytochrome P-450: evidence against cytochrome P-450 isozyme:isozyme interactions.

D R Dutton, S K McMillen, A J Sonderfan, P E Thomas, A Parkinson.   

Abstract

The aim of the present study was to examine a recent proposal that inhibitory isozyme:isozyme interactions explain why membrane-bound isozymes of rat liver microsomal cytochrome P-450 exert only a fraction of the catalytic activity they express when purified and reconstituted with saturating amounts of NADPH-cytochrome P-450 reductase and optimal amounts of dilauroylphosphatidylcholine. The different pathways of testosterone hydroxylation catalyzed by cytochromes P-450a (7 alpha-hydroxylation), P-450b (16 beta-hydroxylation), and P-450c (6 beta-hydroxylation) enabled possible inhibitory interactions between these isozymes to be investigated simultaneously with a single substrate. No loss of catalytic activity was observed when purified cytochromes P-450a, P-450b, or P-450c were reconstituted in binary or ternary mixtures under a variety of incubation conditions. When purified cytochromes P-450a, P-450b, and P-450c were reconstituted under conditions that mimicked a microsomal system (with respect to the absolute concentration of both the individual cytochrome P-450 isozyme and NADPH-cytochrome P-450 reductase), their catalytic activity was actually less (69-81%) than that of the microsomal isozymes. These results established that cytochromes P-450a, P-450b, and P-450c were not inhibited by each other, nor by any of the other isozymes in the liver microsomal preparation. Incorporation of purified NADPH-cytochrome P-450 reductase into liver microsomes from Aroclor 1254-induced rats stimulated the catalytic activity of cytochromes P-450a, P-450b, and P-450c. Similarly, purified cytochromes P-450a, P-450b, and P-450c expressed increased catalytic activity in a reconstituted system only when the ratio of NADPH-cytochrome P-450 reductase to cytochrome P-450 exceeded that normally found in liver microsomes. These results indicate that the inhibitory cytochrome P-450 isozyme:isozyme interactions described for warfarin hydroxylation were not observed when testosterone was the substrate. In addition to establishing that inhibitory interactions between different cytochrome P-450 isozymes is not a general phenomenon, the results of the present study support a simple mass action model for the interaction between membrane-bound or purified cytochrome P-450 and NADPH-cytochrome P-450 reductase during the hydroxylation of testosterone.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3109324     DOI: 10.1016/0003-9861(87)90399-7

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  5 in total

1.  Effects of ionic strength on the functional interactions between CYP2B4 and CYP1A2.

Authors:  Rusty W Kelley; James R Reed; Wayne L Backes
Journal:  Biochemistry       Date:  2005-02-22       Impact factor: 3.162

2.  CYP2D6-CYP2C9 protein-protein interactions and isoform-selective effects on substrate binding and catalysis.

Authors:  Murali Subramanian; Michael Low; Charles W Locuson; Timothy S Tracy
Journal:  Drug Metab Dispos       Date:  2009-05-15       Impact factor: 3.922

3.  Characterization of Interactions Among CYP1A2, CYP2B4, and NADPH-cytochrome P450 Reductase: Identification of Specific Protein Complexes.

Authors:  J Patrick Connick; James R Reed; Wayne L Backes
Journal:  Drug Metab Dispos       Date:  2017-12-12       Impact factor: 3.922

4.  Immobilized Cytochrome P450 for Monitoring of P450-P450 Interactions and Metabolism.

Authors:  Chris D Bostick; Katherine M Hickey; Lance A Wollenberg; Darcy R Flora; Timothy S Tracy; Peter M Gannett
Journal:  Drug Metab Dispos       Date:  2016-03-09       Impact factor: 3.922

5.  Defining the primary route for lutein synthesis in plants: the role of Arabidopsis carotenoid beta-ring hydroxylase CYP97A3.

Authors:  Joonyul Kim; Dean DellaPenna
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.